Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats
about
Recombinant adeno-associated virus-mediated human kallikrein gene therapy protects against hypertensive target organ injuries through inhibiting cell apoptosis.Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo.Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice.Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state.Relation of plasma tissue kallikrein levels to presence and severity of coronary artery disease in a Chinese population.Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors.CYP2J2 overexpression increases EETs and protects against angiotensin II-induced abdominal aortic aneurysm in mice.The kallikrein-kinin system in health and in diseases of the kidney.Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathyProteases as therapeutics.Antihypertensive and renoprotective effect of the kinin pathway activated by potassium in a model of salt sensitivity following overload proteinuria.Blockade of Bradykinin receptors worsens the dystrophic phenotype of mdx mice: differential effects for B1 and B2 receptors.Telmisartan protects against insulin resistance by attenuating inflammatory response in rats.Association of functional kallikrein-1 promoter polymorphisms and acute kidney injury: a case-control and longitudinal cohort study.
P2860
Q33554981-73787BD6-B21F-413B-81EE-63FE08BC3708Q33557502-F198CA4D-B30E-4B8C-9168-123C7E711CF1Q33750765-A4F2E7B3-7548-406F-BD88-EFF56975AFFAQ35034973-E9A9F4D5-3E8C-421B-8A46-89E23D2043CAQ35120196-11DBA956-0224-4286-849C-F0A0CFD4CA81Q35664924-6ED84275-3B93-4FD2-ACC6-3A5FE0CD3876Q36754838-6866A554-9B19-4AE0-AB45-24AC07720028Q37070150-69C9071B-A85C-437F-B6BC-593B1D6A8E7AQ37174951-EC7386BD-0735-4904-AE84-FA64420A0CB4Q37853216-675068DD-B036-45EA-B5EC-0D00E9D545CAQ39172066-86769949-AB92-4043-B7E8-E4071FCF9555Q47776900-FA7620BE-30E1-406D-98CE-64B27DE9EF36Q51372097-D6123E51-1C7A-4D8D-BE03-D265B05FDA75Q55380495-4B578DD6-8D65-45AA-8255-84286B655E01
P2860
Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Delivery of recombinant adeno- ...... chronic renal failure in rats
@ast
Delivery of recombinant adeno- ...... chronic renal failure in rats
@en
type
label
Delivery of recombinant adeno- ...... chronic renal failure in rats
@ast
Delivery of recombinant adeno- ...... chronic renal failure in rats
@en
prefLabel
Delivery of recombinant adeno- ...... chronic renal failure in rats
@ast
Delivery of recombinant adeno- ...... chronic renal failure in rats
@en
P2093
P2860
P356
P1433
P1476
Delivery of recombinant adeno- ...... chronic renal failure in rats
@en
P2093
Changqing Zhou
Dao Wen Wang
Darryl C Zeldin
Huaibing Wan
James W Voltz
Juanjuan Deng
Matthew L Edin
P2860
P304
P356
10.1089/HUM.2007.138
P577
2008-04-01T00:00:00Z